JWH 182 is a potent synthetic cannabinoid (CB), activating the central CB1 receptor with a Ki of 0.65 nM and the peripheral CB2 receptor with a Ki of 1.1 nM. Its effects in cells and animals are unknown. References: Hondebrink L, Zwartsen A, Westerink RHS. Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data? Pharmacol Ther. 2018 Feb;182:193-224. doi: 10.1016/j.pharmthera.2017.10.022. Epub 2017 Oct 31. Review. PubMed PMID: 29097307.

纯度：≥98%

CAS：824960-02-3